CAR T-Cell Therapy for Multiple Myeloma

CAR T-cell therapy is an innovative procedure that uses your own immune system to seek and destroy cancerous cells. The CAR T-cell process begins with the patient’s blood being drawn. White blood cells (specifically, T-cells, an essential part of the immune system) are then separated from the rest of the blood using advanced technology. The white blood cells are subsequently sent to a specialized laboratory, where they are engineered to produce specific chimeric antigen receptors (CARs) on their surface. These CAR T-cells are then injected back into the patient’s bloodstream, where the new CARs can help them latch on to an antigen on tumor cells – significantly increasing their ability to effectively hunt down and destroy malignancies.

While the treatment was limited to acute lymphocytic leukemia, non-Hodgkin’s lymphoma, and acute myelogenous leukemia patients until recently, CAR T-cell therapy is now approved for the treatment of multiple myeloma.

Unfortunately, as a cutting-edge treatment, CAR T-cell therapy is only available at a handful of medical institutions worldwide, and tends to be an expensive and prolonged process. The number of adults who have undergone this therapy CAR T-cell therapy at Sheba:

One of the 10 best hospitals in the world according to Newsweek magazine, Sheba is dedicated to providing patients with world-class medical care. At Sheba Medical Center, we boast all of the advanced facilities necessary for delivering CAR T-cell therapy from start to finish: including a dedicated laboratory to engineer the T-cells. This shortens the treatment process from many months to no more than 10 weeks.

Advantages of treatment at Sheba Medical Center include:

• As a government institution, we have no hidden costs, and our fees are transparent. Although we offer advanced treatments available only in select medical institutions worldwide, our prices are affordable.
• Sheba treats each patient as a unique individual, personalizing every therapy program.
• Sheba’s 360-degree care approach to every patient means that our professionals will assist you with arranging medical record reviews, travel, visas, accommodations, and language interpretation as needed.
• Sheba has full accreditation from the Joint Commission International (JCI), the premier international healthcare accrediting group.
• Our physicians are actively involved in the latest research and application of progressive treatments.
• Sheba’s extensive experience with CAR T-cell therapy speaks louder than words. Under the expertise of Prof. Arnon Nagler, Director of the Hemato-Oncology Division and a world-renowned specialist in the field, we have provided over 220 patients with CAR T-cell therapy.
• Convenient on-site CAR T-cell care: We offer all of the required services for CAR T-cell therapy under one roof, including blood collection, chemotherapy, a genetic engineering laboratory, T-cell injections, and patient monitoring, resulting in an efficient and expedited treatment.
• Multidisciplinary medicine: at Sheba, specialists from various departments collaborate to create a holistic treatment plan.